Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Working Capital/Sales

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

BAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 19.7210.9116.1614.8621.57

What is the latest Working Capital/Sales ratio of BAL PHARMA ?

The latest Working Capital/Sales ratio of BAL PHARMA is 19.72 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar202519.72
Mar202410.91
Mar202316.16
Mar202214.86
Mar202121.57

How is Working Capital/Sales of BAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 19.72
80.75
Mar2024 10.91
-32.49
Mar2023 16.16
8.75
Mar2022 14.86
-31.11
Mar2021 21.57 -

Other Financial Ratios of BAL PHARMA


Compare Working Capital/Sales ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹122.9 Cr 2.9% 7.5% -16.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

2.9%

7.5%

-16.3%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses